Sorafenib Fails Another Phase 3 Trial in Lung Cancer Sorafenib Fails Another Phase 3 Trial in Lung Cancer
The targeted agent has been investigated in several phase 3 trials of nonsmall-cell lung cancer, but none have been successful. The targeted agent has been investigated in several phase 3 trials of nonsmall-cell lung cancer, but none have been successful. Medscape Medical News (Source: Medscape Medical News Headlines)
Understanding epilepsy miracle diet may lead to better treatments, scientists say
A high-fat, low-carb ketogenic diet is effective in treating children with epilepsy who don't respond to medication but scientists weren't sure how it worked - until now (Source: Health News: CBSNews.com)